Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Peiris

Showing results (411-420 of 661) with videos related to

Pageof 67
Sort By:
Research Square|January 12, 2022
Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccinesMalik Peiris, Samuel Cheng, Chris Ka Pun Mok, et al.
Journal of Clinical Microbiology|July 10, 2004
Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assaySusanna K P Lau, Patrick C Y Woo, Beatrice H L Wong, et al.
The Journal of Infectious Diseases|April 10, 2010
Viral shedding and clinical illness in naturally acquired influenza virus infectionsLincoln L H Lau, Benjamin J Cowling, Vicky J Fang, et al.
Journal of Virology|November 1, 2016
CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In VivoOoiean Teng, Szu-Ting Chen, Tsui-Ling Hsu, et al.
Emerging Infectious Diseases|September 21, 2021
Risk Assessment for Highly Pathogenic Avian Influenza A(H5N6/H5N8) Clade 2.3.4.4 VirusesChristine H T Bui, Denise I T Kuok, Hin Wo Yeung, et al.
The Journal of Infectious Diseases|January 19, 2018
Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017Susan S Chiu, Mike Y W Kwan, Shuo Feng, et al.
Research Square|August 19, 2022
Within-host diversity of SARS-CoV-2 lineages and effect of vaccinationHaogao Gu, Ahmed Abdul Quadeer, Pavithra Krishnan, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2009
DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysisGallen B Triana-Baltzer, Maria Babizki, Michael C W Chan, et al.
Nature Communications|March 24, 2022
Reconstructing antibody dynamics to estimate the risk of influenza virus infectionTim K Tsang, Ranawaka A P M Perera, Vicky J Fang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 13, 2018
Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infectionWan Beom Park, Leo L M Poon, Su-Jin Choi, et al.
Pageof 67

Showing results (411-420 of 661) with videos related to

Sort By:
Pageof 67
Research Square|January 12, 2022
Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccinesMalik Peiris, Samuel Cheng, Chris Ka Pun Mok, et al.
Journal of Clinical Microbiology|July 10, 2004
Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assaySusanna K P Lau, Patrick C Y Woo, Beatrice H L Wong, et al.
The Journal of Infectious Diseases|April 10, 2010
Viral shedding and clinical illness in naturally acquired influenza virus infectionsLincoln L H Lau, Benjamin J Cowling, Vicky J Fang, et al.
Journal of Virology|November 1, 2016
CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In VivoOoiean Teng, Szu-Ting Chen, Tsui-Ling Hsu, et al.
Emerging Infectious Diseases|September 21, 2021
Risk Assessment for Highly Pathogenic Avian Influenza A(H5N6/H5N8) Clade 2.3.4.4 VirusesChristine H T Bui, Denise I T Kuok, Hin Wo Yeung, et al.
The Journal of Infectious Diseases|January 19, 2018
Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017Susan S Chiu, Mike Y W Kwan, Shuo Feng, et al.
Research Square|August 19, 2022
Within-host diversity of SARS-CoV-2 lineages and effect of vaccinationHaogao Gu, Ahmed Abdul Quadeer, Pavithra Krishnan, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2009
DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysisGallen B Triana-Baltzer, Maria Babizki, Michael C W Chan, et al.
Nature Communications|March 24, 2022
Reconstructing antibody dynamics to estimate the risk of influenza virus infectionTim K Tsang, Ranawaka A P M Perera, Vicky J Fang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 13, 2018
Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infectionWan Beom Park, Leo L M Poon, Su-Jin Choi, et al.
Pageof 67